Monday, August 24

Browsing: completed

The new YFQ-44A combat drone completed its second exercise with experimental units of the U.S. Air Force

By healthylife7August 23, 20260

Several weeks after Anduril officially unveiled the YFQ-44A in Ohio, the new combat drone has completed its second exercise with experimental units from the U.S. Air Force (USAF) at Creech Air Force Base, Nevada. The activity expanded the responsibilities assigned to operational personnel and marked another step in preparing the system for future Collaborative Combat Aircraft…

Conditions

Regeneron stock climbs to a 52-week high as FDA approves rare disease drug

By healthylife7August 24, 20260

Regeneron Pharmaceuticals stock (ISIN US75886F1075) is trading near $834 per share as of August 23, 2026, a level that marks a new 52-week high following a powerful post-earnings rally and fresh regulatory progress in rare disease treatment. One recent market analysis notes that the shares moved from a closing price near $651 to about $834…

What's Hot

Regeneron stock climbs to a 52-week high as FDA approves rare disease drug

Hanmi Licenses Obesity Drug to Genentech in $2 Billion Deal

Getting ripped ‘Odyssey’-style at this L.A. sword

Browsing: completed

The new YFQ-44A combat drone completed its second exercise with experimental units of the U.S. Air Force

Regeneron stock climbs to a 52-week high as FDA approves rare disease drug

Hanmi Licenses Obesity Drug to Genentech in $2 Billion Deal

Getting ripped ‘Odyssey’-style at this L.A. sword

Low-fat vegan diet may help people lose weight without eating less: Research

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

Regeneron stock climbs to a 52-week high as FDA approves rare disease drug

Hanmi Licenses Obesity Drug to Genentech in $2 Billion Deal

Getting ripped ‘Odyssey’-style at this L.A. sword

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Browsing: completed